• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

SHUH, Syapse to Build South Korea’s First Real-World Data Sharing Network for Precision Oncology Hospitals

by Jasmine Pennic 08/06/2019 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

SHUH, Syapse to Build South Korea’s First Real-World Data Sharing Network for Precision Oncology Hospitals

SNUH and Syapse will collaboratively work towards building South Korea’s first real-world data-sharing network for leading precision oncology hospitals in the region. 

Syapse, a company accelerating precision medicine through insights derived from its global health system network, and Seoul National University Hospital (SNUH), a South Korea-based hospital, today announced that they have extended their partnership with a new multi-year agreement. As part of their partnership, SNUH and Syapse will collaboratively work towards building South Korea’s first real-world data-sharing network for leading precision oncology hospitals in the region. 

Syapse Network

The Syapse Network enables health systems and their providers to learn from real-world treatment and outcomes data shared by leading institutions. Providers can view which treatments provided the best outcomes for clinically and molecularly similar patients at the point of care with a large pool of real-world data generated by a national network of leading institutions. Insights are accessible to Syapse health system partners through Syapse Oncology.

SNUH’s Innovation Approach to Cancer Care

Established in 1885 as Korea’s first national hospital, SNUH has built a global reputation for innovative approaches to cancer care. SNUH serves more than 8,000 cancer patients per year across 16 Cancer Specialty Centers, 10 Multidisciplinary Cancer Treatment Centers, and a Cancer Clinical Trials Center. The Syapse and SNUH collaboration, established in January 2018, has focused on scaling the delivery of precision medicine insights through the integration and curation of clinical, molecular testing and outcomes data collected in information systems including electronic health records (EHRs).

Syapse Precision Medicine Council Asia

SNUH and Syapse have also announced today that they will co-host the Syapse Precision Medicine Council Asia with support from MegazoneCloud. The inaugural invitation-only symposium for Syapse partners will be held at SNUH in Seoul on November 22 and 23, 2019 and convene clinical and executive healthcare leaders who are dedicated to advancing precision oncology. The Precision Medicine Council is focused on three primary goals: sharing best practices in growing precision medicine programs, generating actionable insights to advance the industry as a whole, and building upon current data-sharing initiatives.

Why It Matters

“We are very pleased to enter into this expanded multi-year agreement with Syapse focused on accelerating the practice of precision medicine,” said Kyung Hwan Kim, M.D., Ph.D., Chief Information Officer at Seoul National University Hospital. “We are proud of the progress we have made together and look forward to continuing our efforts with Syapse to develop the leading precision medicine platform in South Korea and the Asia Pacific region.”

[irp posts=”50001″ name=”Pfizer, Syapse Partner on Oncology Precision Medicine Using Real-World Evidence (RWE)”]

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: cancer, cancer informatics, Clinical Trials, global health, Health Systems, Healthcare Leaders, Oncology, Partners, Pfizer, point of care, Precision Medicine, Precision Medicine Council, Precision Oncology, Real World Evidence (RWE), Syapse, University Hospital

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Kinetik CEO Sufian Chowdhury on Fighting NEMT Fraud & Waste

Most-Read

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

'Cranky Index' Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

‘Cranky Index’ Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

Madison Dearborn Partners to Acquire Significant Stake in NextGen Healthcare

Madison Dearborn Partners to Acquire Significant Stake in NextGen Healthcare

Wandercraft Begins Clinical Trials for Physical AI-Powered Personal Exoskeleton

Wandercraft Begins Clinical Trials for Physical AI-Powered Personal Exoskeleton

Chipiron Secures $17M to Transform MRI Access with Portable Scanner

Chipiron Secures $17M to Transform MRI Access with Portable Scanner

Abbott to Integrate FreeStyle Libre Glucose Data with Epic EHR

Abbott to Integrate FreeStyle Libre Glucose Data with Epic EHR

5 Ways New Trump Administration Tariffs Are Impacting U.S. Healthcare Now

5 Ways Trump Administration Tariffs Are Impacting U.S. Healthcare Now

iCAD, GE HealthCare Integrate to Advance Breast Cancer Detection with AI

RadNet to Acquire iCAD for $103M in All-Stock Transaction

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |